vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
33.50
-0.22 (-0.65%)
At close: May 28, 2026, 4:00 PM EDT
34.17
+0.67 (2.00%)
After-hours: May 28, 2026, 4:32 PM EDT
vTv Therapeutics Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, vTv Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $53. The average 1-year stock price forecast is 58.21% higher than the current stock price, while the lowest is $44 (+31.34%) and the highest is $67 (+100.00%).
Price Target: $53 (+58.21%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for vTv Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 5 | 5 | 6 | 6 | 6 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 5 | 5 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Maintains $67 | Buy | Maintains | $67 | +100.00% | May 14, 2026 |
| Alliance Global Partners | Alliance Global Partners | Buy Reiterates $55 | Buy | Reiterates | $55 | +64.18% | May 14, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $47 → $45 | Buy | Reiterates | $47 → $45 | +34.33% | May 14, 2026 |
| BTIG | BTIG | Buy Maintains $49 | Buy | Maintains | $49 | +46.27% | May 14, 2026 |
| Roth MKM | Roth MKM | Buy Reiterates $58 | Buy | Reiterates | $58 | +73.13% | May 14, 2026 |
Financial Forecast
Revenue This Year
6.80M
Revenue Next Year
816.00K
from 6.80M
Decreased by -88.00%
EPS This Year
-2.98
from -3.20
EPS Next Year
-4.49
from -2.98
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 21.0M | 4.2M | ||||||
| Avg | 6.8M | 816,000 | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | -38.2% | ||||||
| Avg | - | -88.0% | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -1.08 | -3.34 | ||||||
| Avg | -2.98 | -4.49 | ||||||
| Low | -4.69 | -7.65 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.